Daily Stock List
SilverSun Technologies, Inc. (SSNT)
Comcast.net, Penny Stock Rumble, SeriousTraders, and FeedBlitz reported earlier on SilverSun Technologies, Inc. (SSNT), and we are highlighting the Company as "One to Watch" this week here at the QualityStocks Daily Newsletter.
SilverSun Technologies, Inc. engages in the acquisition and build-out of technology and software companies engaged in providing best of breed management applications and professional consulting services to small and medium size businesses (SMBs) in the manufacturing, distribution and service industries. The Company's principal operating subsidiary is SWK Technologies, Inc. SWK employs a national direct sales and consulting team currently serving a growing customer base spanning 38 U.S. States and Canada. SilverSun Technologies lists on the OTC Bulletin Board; the Company is based in Livingston, New Jersey.
SilverSun's SWK Technologies, established in 1988, is a leading Sage Software Partner. SWK is a preferred source for best-of-breed business management applications and professional consulting services. They serve the Greater New York Metro area, New Jersey, as well as Upstate and Western New York.
SWK is a Sage Partner for SAGE ERP X3, Sage MAS 90, Sage MAS 200 ERP, Sage MAS 500 ERP, Sage BusinessWorks and SageCRM, and other related products. SWK provides consulting, installation, customization, training, and support for solutions. They provide their various services on site at the client’s location; on-line by way of instructional webinars; at SWK's Authorized Training Center located in Livingston, New Jersey; as well as through SWK's Help Desk personnel.
SWK also publishes MAPADOC (www.mapadoc.com), their proprietary EDI (Electronic Data Interchange) software. In addition, they provide network services, including 24/7 remote network monitoring, data back-up, and disaster recovery services.
Today, SilverSun Technologies announced that their wholly owned subsidiary, SWK Technologies, closed on a software sale valued at more than $650,000. The transaction involves the sale of Sage Software's ERP X3 software and attendant consulting services.
Mr. Mark Meller, Chairman and CEO of SilverSun Technologies, stated, "SWK's commitment to Sage ERP X3 continues to bear fruit. We made a very large investment in order to train people in our organization on Sage ERP X3, and we are now the leading Sage ERP X3 reseller in North America. While the sales cycle on Sage ERP X3 deals may be longer, the size of the transactions are larger, and as a result, we anticipate announcing additional significant deals in the near future. We expect that the financial results of 2012 will be a record for our Company."
We're tracking SilverSun Technologies, Inc. (SSNT) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.
SilverSun Technologies, Inc. (SSNT), closed Tuesday's trading session at $0.03, down 1.40%, on 250,645 volume with 9 trades. The average volume for the last 60 days is 610,107 and the stock's 52-week low/high is $0.015/$0.06.
TheraBiogen, Inc. (TRAB)
OTCPicks and SmallCapVoice reported earlier on TheraBiogen, Inc. (TRAB), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Founded in 2000, TheraBiogen, Inc. is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The Company makes their products from natural, homeopathic ingredients. The products contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. TheraBiogen has their headquarters in Freehold, New Jersey. The Company's shares trade on the OTC Bulletin Board.
Currently, the Company's business model is as a developer and manufacturer of Over-The-Counter (OTC) homeopathic pharmaceutical products that assist in the relief of various symptoms and illnesses. The Company has products for which they have licensed the formulation from a third party. TheraBiogen sells those products to the consumer via third parties. TheraBiogen's typical client is a pharmaceutical retail chain or a grocery retail chain.
The Company has decided to focus their efforts for the near future on marketing directly to the consumer online. They will continue to support their retail outlet customers but not look for any additional programs because of the cost of getting and keeping their products on the retailer's shelves. The Gross Profit margins in online direct-to-consumer are generally much higher. The Company believes that this may enable them to grow TheraBiogen with less investor capital.
TheraBiogen is working on adding more products to their Thera Max product line, whether developed internally or acquired or licensed from others. They have developed Thera Max Sore Throat Relief, in addition to the existing Thera Max Cold and Flu relief, Thera Max Allergy Relief and Thera Max Migraine Relief.
TheraBiogen's "Thera Max® Cold and Flu" product is an all natural, non-zinc, non-addictive, OTC cold and flu relief agent. Thera Max® is available for purchase in more than 12,000 locations. These include Rite-Aid, Food Lion, and Hannaford Supermarkets, Discount Drug Marts and Big Y Supermarkets as well as two of the three largest drug retailers.
TheraBiogen, Inc. (TRAB), closed Tuesday's trading session at $0.0061, up 60.53%, on 1,479,810 volume with 48 trades. The average volume for the last 60 days is 114,276 and the stock's 52-week low/high is $0.0011/$0.085.
Dataram Corp. (DRAM)
SmarTrend Newsletters, DrStockPick, PennyOmega, Bestotc, PennyToBuck, CRWEFinance, CRWEPicks, CRWEWallStreet, and StockHotTips reported on Dataram Corp. (DRAM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the NASDAQ Capital Market, Dataram Corp. is a global leader in the manufacture of high-quality computer memory, storage and software products. The Company's solutions are deployed in 70 Fortune 100 companies and in mission-critical government and defense applications worldwide. Dataram has embarked on a major growth plan that includes significant R&D investment into new product lines, acquisition of new companies, and substantial organic growth associated with the Company's existing memory product line. Founded in 1967, Dataram has their corporate headquarters in Princeton, New Jersey.
The Company's products and services deliver Information Technology (IT) infrastructure optimization, significantly increase application performance and deliver substantial cost savings. Dataram maintains a major presence within civilian governmental agencies and the Department of Defense (DoD) who use their products for the most demanding mission critical applications. Additionally, the Company serves many mid-tier customers. Dataram's customers also include a number of major equipment manufacturers who need embedded memory or storage solutions.
In early September, Dataram announced that they entered into a formal agreement with Advanced Micro Devices, Inc. (AMD) to develop an AMD-branded version of Dataram's RAMDisk software. Dataram will market the product under the name Radeon RAMDisk. They will target gaming enthusiasts looking for exponential improvements in game load times leading to an enhanced gaming experience. AMD intends to offer special Radeon RAMDisk incentives for those purchasing AMD Value, Entertainment, Performance and Radeon Edition memory products.
In the fiscal first quarter ended July 31, 2012, Dataram entered into an agreement with Shoreline Memory, Inc. for expanding their customer base and product offerings. The Shoreline Agreement provides for Dataram to fulfill 50 percent of the orders Shoreline receives from their primary customers.
Recently, Dataram reported their financial results for the Company's fiscal first quarter ended July 31, 2012. Revenues for the first quarter were $8.0 million; this compares to $7.0 million in the previous quarter and $10.3 million for the comparable prior year period. Dataram's net loss for the first quarter totaled $976,000, or $0.09 per share. This compares to a net loss of $854,000, or $0.08 per share for the comparable prior year period.
Dataram Corp. (DRAM), closed Tuesday's trading session at $0.64, up 12.46%, on 11,150 volume with 43 trades. The average volume for the last 60 days is 8,551 and the stock's 52-week low/high is $0.50/$1.37.
Oryon Technologies, Inc. (ORYN)
Epic Stock Picks reported today on Oryon Technologies, Inc. (ORYN), Paragon Report, StocksGoneWild, EpicVIP Group, PennyDoctor reported on the Company yesterday, and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Oryon Technologies, Inc. is a research and development, and applications engineering company. The Company is a developer and manufacturer of the innovative next-generation, flexible, crushable, water resistant and wearable lighting technology known as ELastoLite®. Oryon Technologies acquired the initial elastomeric electroluminescent lighting technology patents and intellectual property in 2002.
Oryon Technologies lists on the OTCQB. The Company has their headquarters in Addison, Texas. Oryon's target textile market includes outerwear, industrial safety, municipal safety, military, athletic apparel, men's, women's and children's clothing, shoes and gear.
Oryon has developed multiple patents relating to electroluminescent (EL) lighting (trademarked as the aforementioned ELastoLite®). ELastoLite® enables thin, flexible, crushable, water-resistant lighting systems to undergo incorporation into multiple applications. These include safety apparel, sporting goods, consumer goods and membrane switches, among others.
The Company is focusing at first on developing solutions for the textile, apparel (specifically sports and safety), and membrane switches industries. This is where their technology has already undergone deployment and achieved market acceptance. Oryon's technologies are heavily patented; this creates significant "barriers to entry" for potential competitors. More than 55 patents issued or pending globally protect the technologies.
One of Oryon Technologies' early successes in commercializing their Intellectual Property (IP) was licensing the use of the technology in cell phone key pads. This led to the back lighting of the key pad in the Motorola RAZR. ELastoLite® has been featured in apparel products sold by Nike, Lands' End and Marmot Mountain Ltd.
Last week, Oryon Technologies announced that they closed a private placement capital raise resulting in gross proceeds of $2,000,000. The Financing Agreement was previously disclosed in Oryon's Current Report on Form 8-K, as amended, dated May 4, 2012. To date, the Company has now received an aggregate amount of $2 million from the issuance of common stock to investors who are "accredited investors," as defined under the Securities Act. Oryon will use the proceeds from the subscriptions for general corporate purposes.
Oryon Technologies, Inc. (ORYN), closed Tuesday's trading session at $0.78, down 2.50%, on 126,725 volume with 76 trades. The average volume for the last 60 days is 284,127 and the stock's 52-week low/high is $0.40/$1.33.
SMA Alliance, Inc. (SMAA)
PhD-Trading reported today on SMA Alliance, Inc. (SMAA), Pumps and Dumps did yesterday; Goldman Small Cap Research, Wallstreet Profiler, OtcWizard, Stocks that Move, Hot Stock Profits did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Nashville, Tennessee, SMA Alliance, Inc. operates as a software application company. They provide marketing and advertising solutions through targeting Internet applications focused on lead generation. The Company, by using their managed system technologies, consistently provides buying demand on a daily basis for clients through application and continued development of their proprietary technology systems. SMA Alliance lists on the OTC Pink Current Information.
SMA Alliance is an Auto Dealer Marketing Company. The Company is the first internet program designed to act as a Lead Generator rather than a Lead Provider. They place all of a Dealership's Used Car Inventory in advertisements that they place on all of the most popular classified websites on the internet. They generate leads (phone calls, internet inquiries and online credit requests) for their Dealers via targeted listings based on that Dealers specific inventory.
Last week, SMA Alliance announced the completion of their lead distribution software designed specifically for luxury car dealerships and franchises. The Company will immediately begin the pre-selling of this highline automotive technology to a core group of dealers' intent on constant consumer flow. With this advancement, SMA Alliance has received approval by Lexus to pursue Lexus automotive dealerships with their lead generation programs. Starting in the fourth quarter, SMA will be pursuing equivalent approvals from Mercedes and BMW.
Yesterday, SMA Alliance announced that they would be opening a satellite office in Tampa, Florida in the fourth quarter of 2012. This new office will focus on working with larger automotive manufacturing clients and automotive groups. The staff will also consist of bilingual employees. This is to assist with the large amount of Spanish speaking buyers and dealers in the automotive market. The facility that the Company chooses will house the entire SMAA IT division, from their employees to the Company's server farms.
SMA Alliance CEO, Mr. Timothy Stephens, stated, "SMAA's expansion in the Florida region will provide our client dealers with centralized IT support and maintenance so that we are able to provide the excellent level of service expected from us as we add new dealers and manufacturers to our client database. By centralizing our IT division, SMAA will be able to handle even more clients' marketing needs. By staffing bilingual representatives, we will increase our expected market reach."
SMA Alliance, Inc. (SMAA), closed Tuesday's trading at $0.12, even for the day, on 1,135,168 volume with 136 trades. The average volume for the last 60 days is 247,428 and the stock's 52-week low/high is $0.015/$0.43.
Pershing Gold Corp. (PGLC)
Streetwise Reports, Stockhouse, SmallCapVoice, and Bullish Bankers reported earlier on Pershing Gold Corp. (PGLC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Pershing Gold Corp. (formerly known as Sagebrush Gold Ltd.) is a gold and precious metals exploration company with headquarters in Lakewood, Colorado. The Company is pursuing exploration and development opportunities primarily in Nevada. Currently, they are focusing on exploration at their Relief Canyon properties (Pershing County in northwestern Nevada). None of the Company's properties contains proven and probable reserves. All of their activities on all of their properties are exploratory in nature. Pershing Gold's shares trade on the OTCQB.
The Company acquired the former Relief Canyon Mine property in August of 2011. This includes a processing plant that they could use in mining operations if their exploration efforts are successful. Pershing Gold started an exploration drilling program in 2011 that is continuing this year. The Company has expanded their Relief Canyon property position in 2012 significantly. They accomplished this with the acquisition of the Pershing Pass and Relief Canyon Expansion properties.
The Relief Canyon Mine, Pershing and Relief Canyon Expansion properties are collectively called the Relief Canyon properties. The Company's intention is to continue to acquire additional mineral targets in Nevada and elsewhere where they believe they have the potential to quickly expand and advance known mineralization and the potential to discover new deposits.
Recently, Pershing Gold provided an update of the many achievements realized in the Company's first year of owning the Relief Canyon Mine property in Pershing County, Nevada. Since acquiring this property out of bankruptcy in August 2011, Pershing Gold is well on their way to putting this long-neglected gold mine into production. Furthermore, the Company is conducting an aggressive exploration program that has already found new mineralized zones outside of the existing open-pit mine that are expected to substantially increase the mineral resource.
Because of this exploration work, the Company's geologists have developed a new exploration model; this model is focusing on three styles of mineralization. This refined understanding of the geology of the Relief Canyon ore deposit has identified several high-priority targets that are the focus of Pershing Gold's exploration drilling campaign.
Immediately after acquiring the Relief Canyon Mine property, the Company initiated a drilling program. This drilling program has discovered gold in many drill holes that Pershing Gold expects to upgrade as well as expand the resource attributable to the Relief Canyon Mine property. Pershing Gold is planning to release an NI 43-101 Technical Report in the fourth quarter of 2012 to document the expanded resource.
Pershing Gold Corp. (PGLC), closed Tuesday at $0.43, up 4.88%, on 675,920 volume with 128 trades. The average volume for the last 60 days is 482,515 and the stock's 52-week low/high is $0.252/$0.97.
Evolucia, Inc. (ILED)
Today we are reporting on Evolucia, Inc. (ILED), here at the QualityStocks Daily Newsletter.
Evolucia, Inc. formerly went by the name Sunovia Energy Technologies, Inc. Evolucia, Inc., (OTCBB and OTCQB: ILED), replaced the Sunovia Energy Technologies, Inc. corporate name and the SUNV stock ticker effective August 16, 2012. Evolucia is an industry pioneer in the design, engineering, manufacture and marketing of high performance LED lighting systems to worldwide lighting markets. Founded in 2005, the Company has their corporate headquarters in Sarasota, Florida.
Evolucia received the United States Department of Energy's highest award for lighting within the LED category. The Company has installed thousands of their fixtures at military bases, universities, municipalities, and large commercial entities. Their LED lighting products sell under the brand, Evolucia Lighting. All Evolucia products offer highly energy efficient, durable, commercial-grade LED lighting for indoor and outdoor applications.
The Company's award winning Cobra Head and Shoebox fixtures employ Evolucia's proprietary Aimed Optics™ technology. This technology increases light levels and visibility by strategically directing light to the target area. Evolucia fixtures require 50 percent-80 percent less energy than traditional lighting. They last for approximately 12 years without maintenance.
The Evolucia ESB Shoebox Area Light delivers consistent color, aimed optics and optimal performance that provide a bright white light and the lowest energy consumption. The Evolucia LED Cobra Head luminaire lights the way efficiently and safely.
The Evolucia Cobra Head SCHX5 received the award for Best Outdoor Streetlight, in its class, by the US Department of Energy (DOE), the International Association of Lighting Designers (IALD), and the Illuminating Engineering Society (IES) in the 2010 Next Generation Luminaires™ Solid State Lighting Design Competition. In Europe, Evolucia technology received recognition from the Commission of the Competition for the Best Product in the 19th International Fair of Lighting Equipment LIGHT 2011 for the LED lamp Cobra Head. Evolucia technology also received the Leader of Sustainable Development award, during the 5th Economic Forum "Energy and Environment" in Warsaw, Poland.
Recently, Evolucia announced the appointment of Mr. Charles B. Rockwood as the Company's Executive Vice President and Chief Financial Officer. Mr. Rockwood brings 25 years of financial and operational experience to Evolucia. He has a specialized background in public and regulated environments.
Evolucia, Inc. (ILED), closed Tuesday's session at $0.03, down 1.40%, on 250,645 volume with 9 trades. The average volume for the last 60 days is 610,107 and the stock's 52-week low/high is $0.015/$0.06.
Bioniche Life Sciences, Inc. (BNC.TO)
AllPennyStocks reported previously on Bioniche Life Sciences, Inc. (BNC.TO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Bioniche Life Sciences, Inc. is a research-based, technology-driven, fully integrated Canadian biopharmaceutical company whose shares trade on the Toronto Stock Exchange. The Company focuses on the discovery, development, manufacturing, and marketing of proprietary and innovative products for human and animal health markets globally. Bioniche Life Sciences has three operating divisions: Human Health, Animal Health, and Food Safety. Founded in 1979, the Company has their headquarters in Belleville, Ontario.
The Human Health business division engages in the research, discovery, and clinical development of human health products. They develop Urocidin, a formulation of Mycobacterial Cell Wall-DNA Complex that is in Phase III clinical testing for the treatment of non-muscle-invasive bladder cancer.
Bioniche Animal Health develops, manufactures and markets veterinary biopharmaceutical products around the world. In North America, this division has development, manufacturing and marketing facilities in Belleville, Ontario, Athens, Georgia, and Pullman, Washington. In Australia, they conduct business in Sydney, New South Wales (sales and marketing, customer support and technical service), and Armidale, New South Wales (research, development and manufacturing facilities).
The Food Safety business division offers biopharmaceutical animal health products to prevent disease in humans and improve the safety of food and water supplies. This division develops and commercializes Econiche, a cattle vaccine, used to reduce the spread of E. coli O157 bacteria.
In September, Bioniche Life Sciences announced that one of the Company's equine products - HIPPIRON™ 1000 - was counterfeited, and was discovered being sold through an Internet website. Regulatory authorities and veterinarian customers have been advised of this situation, along with the elements of the counterfeited product that clearly distinguish it from legitimate HIPPIRON™ 1000.
Bioniche's HIPPIRON™ 1000 fully complies with regulatory standards and is safe for use as recommended. Bioniche sells this injectable iron-sucrose product exclusively to veterinarians and it is the only licensed product of its kind available for veterinary use in Canada. HIPPIRON™ has been registered with Health Canada; it meets all regulatory guidelines for manufacture, testing, and quality assurance.
Bioniche Life Sciences, Inc. (BNC.TO), closed Tuesday's trading session at $0.54, down 3.57%, on 82,000 volume. The stock's 52-week low/high is $0.32/$0.95.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.25, off by 4.91%, on 90,988 volume with 28 trades. The stock’s average daily volume over the past 60 days is 106,766, and its 52-week low/high is $0.21/$0.835.
International Stem Cell Corp. congratulated Sir John Gurdon and Dr. Shinya Yamanaka on the recently announced Nobel Prize in Physiology or Medicine for discovering cellular reprogramming to create pluripotent stem cells today. These discoveries lead to the development of induced pluripotent stem cells (iPS, now a major area of research), which unfortunately are currently made using virus-inserted genetics and similarly unsafe techniques. ISCO has developed a technology that potentially allows for the creation of a new generation of iPS cells without these safety concerns, a technology also characterized by the capacity to fine tune results with a much higher level of control.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp Discusses Its New Cellular Reprogramming Technology in View of the Recent Award of the Nobel Prize in Physiology or Medicine
International Stem Cell Corp to Participate in Upcoming Investor Conference
International Stem Cell Corp Granted Key Patent for Liver Disease Program
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $3.96, up 30.69%, on 113,373 volume with 140 trades. The stock’s average daily volume over the past 60 days is 31,213, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech Signs Agreement With Government of Malawi to Open an Oncology & Infectious Disease Clinic at Queen Elizabeth Central Hospital
TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical Officer
MusclePharm Corp. (MSLP)
The QualityStocks Daily Newsletter would like to spotlight MusclePharm Corp. (MSLP). Today, MusclePharm Corp. closed trading at $0.01, up 22.64%, on 113,952,159 volume with 225 trades. The stock’s average daily volume over the past 60 days is 5,566,277, and its 52-week low/high is $0.0053/$0.0375.
MusclePharm Corp. (MSLP) is focused on providing a full line of Informed Choice-approved nutritional supplements that not use any substances banned in the sports industry. Now sold in more than 120 countries and available in over 10,000 U.S. retail outlets, the company's products address all categories of an active lifestyle, including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen.
Current CEO Brad Pyatt founded the company to develop a superior line of nutritional supplements that would help fellow athletes improve their performance in a way that existing supplements did not. Even as the company has grown, its mission has remained the same: to improve its customers' lives, increase their ability to excel, use cutting-edge science to develop the best nutritional supplements on the market, and provide a safe option for athletes.
MusclePharm's products were developed through exhaustive research at the MusclePharm Sports Science Center Research Institute. New products are created through a six-stage research protocol that involves the expertise of top nutritional scientists. Before launching a product, the company conducts field testing using a pool of over one hundred elite professional athletes from various professional sports leagues, including the National Football League, Mixed Martial Arts, and Major League Baseball.
Over the last few years, the consumption of sports nutrition products has shifted to mainstream consumers who have become the key drivers of growth within the industry. Teenagers and college students, women, and even older individuals are now using these products to help them live a more active and healthier lifestyle. With a full line of supplements and an extensive distribution network, MusclePharm is well positioned to capitalize on the growing demand. Disclaimer
MusclePharm Corp. Company Blog
MusclePharm Corp. News:
MusclePharm Wins Three Prestigious Bodybuilding.com Awards, Including Brand of the Year, Upon Fitness Enthusiasts' Votes
MusclePharm Adds Dick's Sporting Goods To Its Growing Retail Distribution
United States Sports Academy Researchers Present Clinical Trial Results For MusclePharms' Assault™ Pre-Workout
Skinny Nutritional Corp. (SKNY)
The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.006, off by 2.86%, on 1,133,277 volume with 17 trades. The stock’s average daily volume over the past 60 days is 1,410,547, and its 52-week low/high is $0.003/$0.041.
Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.
The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.
The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.
Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer
Skinny Nutritional Corp. Blog
Skinny Nutritional Corp. News:
Skinny Nutritional Corp. to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+
A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration
Skinny Nutritional Corp. Enters Into $15M Financing, Positions Company to Grow Skinny Brand Portfolio Nationally
International Stem Cell Corp., a California-based biotechnology company focused on therapeutic and research products, today applauded Sir John Gurdon and Dr. Shinya Yamanaka for securing the Nobel Prize in Physiology or Medicine. The team’s use of cellular reprogramming to create pluripotent stem cells has led to the development of induced pluripotent stem cells (iPS), which is now a major area of research. However, cellular reprogramming is currently accomplished by inserting genetic material, via a virus or otherwise, which raises serious safety concerns when developing treatments.
ISCO, in comparison, has developed a technology that could enable the creation of a new generation of iPS cells without these safety concerns. Unlike methods requiring the use of viruses or DNA constructs that may integrate into the genome, ISCO’s new method utilizes only proteins which are naturally eliminated once they have served their purpose.
“Overall, our new technology represents a level of control that is much finer than the multiple infections necessary for viral-based systems which cannot be turned off and where the dosage level cannot be modulated,” stated Dr. Ruslan Semechkin, Vice President and head of ISCO’s Research and Development. “Moreover, ISCO’s method can be used not only to reprogram somatic cells to become stem cells, but also transform stem cells into somatic cells. This technology provides an alternative to the existing cellular reprogramming methods and represents an enormous opportunity for ISCO to become a leader in the iPS field.”
For additional information on ISCO, visit www.InternationalStemCell.com
GreenHunter Energy, the established provider of Total Water Management Solutions™ to hydrocarbon developers in the burgeoning domestic shale plays, reported today that the company’s wholly-owned subsidiary, GreenHunter Water, LLC, kicked off the start of commercial operations at their Karnes County, Texas, salt water disposal (SWD) facility in the heart of Eagle Ford territory.
Word that the company has started handling water at the Class II SWD facility will no doubt spread quickly among regional operators engaged in the play, and the level of engineering the company has put into the Eagle Ford program is clearly evident in this latest execution of their completion technique. Expansion of salt water disposal capacity is important to the lifespan of the Eagle Ford, and GRH has come to the table with a very adaptive approach, growing on the company’s rich proficiencies in a wide variety of technological solutions to the complex fluid management tasks that face exploration and production companies today.
This announcement regarding the newly drilled 7,800-foot deep (completed in the Middle Wilcox formation) SWD, brings GRH’s total disposal capacity up to 35k bbls/day. Now with seven wells in five states across the U.S., GreenHunter has the kind of muscle needed to take their full-spectrum water solutions strategy to the next level. With a host of other offerings like their Frac-Cycle™ technology (which let’s operators take in flowback or produced water, recycling it into to either clean brine or fresh water), the versatile MAG Tank™ line of modular above-ground storage tanks, and their RAMCAT™ real-time online well head management system, GRH has created a truly enviable position in water management support for the E&P sector.
The new well actually went online weeks ago and the company has just been scaling up throughput to the commercial debut announcement, giving the facility a final once-over, including the new storage tanks, 2,400 bbls of on-site storage, the four-bay tractor trailer platform, and the 150 HP pumping system.
President and COO of GRH, Jonathan D. Hoopes, commented on this latest addition to the company’s growing portfolio of salt water disposal infrastructure, saying that the rising demand for Class II injection capacity was in direct correlation to GRH’s growth strategy, noting that continued successes by drilling in the Eagle Ford’s primary targets was producing huge demand for disposal capacity. The future looks very bright for the company’s Texas operations as activity in the Eagle Ford continues to mount and shareholders will be pleased to note that the company has once again gone to great lengths to meet the most exacting engineering specifications for the Class II SWD standard.
GreenHunter Energy, please visit www.GreenHunterEnergy.com
Echelon, a global leader in energy control networking for smart grid, smart city, and smart building applications, announced today that the company had reached a significant goal in China, a key targeted growth region. Through its joint venture, Zhejiang Echelon Holley Technology Co., Ltd., Echelon was granted China State Grid approval for the use of its power line communications (PLC) technology and Control Operating System (COS) powered data concentrator module. The joint venture has also received its first order for meter modules that incorporate Echelon’s PLC technology, from Holley Metering Limited, for use in a 30,000 smart meter pilot deployment in Inner Mongolia. Additionally, the company has been selected for a pilot in Fuping County, which is located in the Shanxi province.
Because China is a high-growth target for Echelon, these two projects present significant opportunity for the business. Inner Mongolia alone is expected to add 10 million new smart meters over the next five years, while Shanxi province is also targeting 10 million new smart meters over the next three years.
Starting three years ago, the initial Inner Mongolia project began using other PLC technologies. However, due to Echelon’s reputation and renowned PLC technology, Inner Mongolia has selected Echelon for this 30,000 unit deployment now that the Echelon Holley joint venture’s meter module that incorporates Echelon’s PLC technology has received State Grid certification. The deployment is anticipated to be completed in January 2013; the utility already has plans to expand to a larger scale following completion.
The Fuping pilot is being managed by the local utility, part of the Shanxi provincial utility. The 1,000 meter pilot using Echelon PLC technology has delivered nearly a 100% read rate. It is expected that many more meters using the Echelon Holley joint venture communications modules will be installed over the next few months to expand this pilot. This serves as a significant opportunity for Echelon: if the Fuping pilot performs well, it could well expand to other cities or countries in the Shanxi province that are serviced by the same Shanxi utility.
In addition to its pilot projects, the Echelon Holley joint venture has also sold its communications modules (that incorporate Echelon technology) for use in 11,000 smart meters in smaller pilot projects at 10 sites in five provinces.
“Echelon’s strategy of bringing our Energy Control Networking platform to China via our joint venture and local smart grid partners is starting to show results,” said Ron Sege, chairman and CEO of Echelon. “This is part of our company’s strategy to target growing markets and lay the groundwork for selling multi-application edge-of-the-grid solutions around the globe with great local partners such as Holley Metering.”
China State Grid Corporation, a state owned enterprise and the world’s largest grid operator and power distributor, has outlined and is aggressively delivering on its five year plan to upgrade China’s electricity grid. State Grid promises reliability of no less than 99.9% and an on-site response time of 45 minutes to repair service in urban areas. To meet this level of reliability, China State Grid developed a rigorous set of tests that all vendors must pass in order to participate in the future State Grid project to upgrade its 120 million meter market over the next three years.
Marley Coffee, a sustainably grown, ethically farmed and artisan roasted gourmet coffee, today announced the addition of Chris Hopkins as Senior Vice President of National Accounts.
In his new role, Hopkins, who has more than 20 years of food and beverage sales experience, will be responsible for continuing to expand distribution of Marley Coffee through supermarkets, specialty retailers and convenience stores throughout the United States. Prior to joining Marley Coffee, Hopkins paved the way for Marley Beverages as SVP of National Accounts, securing distributions and partnerships with 80 of the top 100 retail outlets, including 7 Eleven, Kroger and Wegmans, which helped drive Marley’s Mellow Mood first year sales of one million cases, which has grown to almost three million cases after two years in the market.
“I saw Chris’ dedication and passion to see a brand grow, and grow quickly, through his tireless work to introduce Marley’s Mellow Mood,” said Rohan Marley, founder of Marley Coffee. “I’m happy we were able to convince Chris to join our team at Marley Coffee as we continue to build our retail distribution in the US and beyond.”
“With Chris’ proven track record in the food and beverage industry, and more recently with Marley Beverages, we’re thrilled to have him join the Marley Coffee team,” said Brent Toevs, CEO, Marley Coffee. “A huge opportunity to expand nationally lies with Chris, and after seeing him engage with buyers at National Products Expo East in Baltimore, we are confident in his ability to secure partnerships that make sense for the brand’s growth.”
In addition to his work with Marley Beverages, Hopkins spent 13 years at Dr Pepper Snapple Group (previously Cadbury Beverages), where he helped start and develop their category management team within their distribution network, and eventually into top national accounts. He also secured several, first ever, strategic partnerships with Kroger, Safeway, Target, Food Lion, and Meijer, where he placed teams on-site with retailers to help drive significant sales through translating consumer insights into action on shelving, pricing, innovation, and promotional strategies for most beverage categories. Hopkins has also worked with Fleming Foods and Kellogg Sales Company.
“I’m thrilled to be a part of the Marley Coffee movement, and expect to be able to take this brand to the next level nationally,” said Hopkins. “I really believe in Marley Coffee’s products and values, and I believe retailers will understand and appreciate the opportunity to carry Marley Coffee in their stores.”
All Marley Coffee products live up to the Rastafari standards of ITAL, standing for all things Pure, True and Vital. A portion of all sales of Marley Coffee supports Kicks for Cause and 1Love.org. Started by Marley Coffee, Kicks for Cause aims to build playable soccer fields and soccer camps for children of coffee-producing communities in Jamaica.
Today's Top 3
The QualityStocks Public Company Sponsor News